If anyone is going ask them how they calculated that 40% sp increase in fy17 in the annual report they were patting themselves on the back for and justifying hitting their perfornance kpis to get bonuses...40c today clowns, is that pathetic performance in the middle of a SBB also one of the kpi's?! I would assume not. Justifying or voting yes for management on any renumeration measure is a slap in the face to long time hurting retail shareholders, no matter how they spin it...the share price is an absolute disgrace and management should not be rewarded for it.
If anyone is going ask them how they calculated that 40% sp...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DNA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $38.29M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 24193 | 3.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.4¢ | 166666 | 1 |
View Market Depth
| Last trade - 16.12pm 11/09/2024 (20 minute delay) ? |
| DNA (ASX) Chart |
Day chart unavailable